Orbimed Advisors - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$14,170,000
+50.3%
82,0000.0%0.12%
+34.4%
Q4 2014$9,425,000
-78.6%
82,000
-70.9%
0.09%
-80.4%
Q3 2014$44,060,000282,0000.46%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Zurcher Kantonalbank (Zurich Cantonalbank) 173,845$7,037,0000.28%
AMUNDI ASSET MANAGEMENT US, INC. 537,900$21,774,0000.09%
NOMURA HOLDINGS INC 127,903$5,175,0000.06%
GOLDMAN SACHS GROUP INC 386,458$15,641,0000.01%
AQR Capital Management 26,000$1,052,0000.01%
GOLDMAN SACHS GROUP INC 100,000$4,047,0000.00%
RATIONAL ADVISORS LLC 288$12,0000.00%
HSBC HOLDINGS PLC 5,448$220,0000.00%
View complete list of SALIX PHARMACEUTICALS INC shareholders